{
    "company_name": "INVEX THERAPEUTICS LTD",
    "address": "Level 2, 38 Rowland Street, SUBIACO, WA, AUSTRALIA, 6008",
    "summary": "Biopharmaceuticals.",
    "details": "Biopharmaceuticals.",
    "website": "http://www.invextherapeutics.com",
    "stock_code": "IXC",
    "links": "['#content', 'https://invextherapeutics.com', 'https://invextherapeutics.com/', '#', 'https://invextherapeutics.com/company-overview/', 'https://invextherapeutics.com/directors-management/', 'https://invextherapeutics.com/corporate-governance/', 'https://invextherapeutics.com/development-strategy/', '#', '#', 'https://invextherapeutics.com/asx-announcements/', 'https://invextherapeutics.com/company-reports/', 'https://invextherapeutics.com/presentations/', 'https://invextherapeutics.com/analyst-reports/', 'https://invextherapeutics.com/share-registry/', 'https://invextherapeutics.com/contacts/', 'https://invextherapeutics.com/publications/', 'https://invextherapeutics.com/fact-sheets/', '#', 'https://invextherapeutics.com/articles/', 'https://invextherapeutics.com/careers/', 'https://invextherapeutics.com/careers/current-openings/', 'https://invextherapeutics.com/contact-us/', 'https://invextherapeutics.com/', '#', 'https://invextherapeutics.com/company-overview/', 'https://invextherapeutics.com/directors-management/', 'https://invextherapeutics.com/corporate-governance/', 'https://invextherapeutics.com/development-strategy/', '#', '#', 'https://invextherapeutics.com/asx-announcements/', 'https://invextherapeutics.com/company-reports/', 'https://invextherapeutics.com/presentations/', 'https://invextherapeutics.com/analyst-reports/', 'https://invextherapeutics.com/share-registry/', 'https://invextherapeutics.com/contacts/', 'https://invextherapeutics.com/publications/', 'https://invextherapeutics.com/fact-sheets/', '#', 'https://invextherapeutics.com/articles/', 'https://invextherapeutics.com/careers/', 'https://invextherapeutics.com/careers/current-openings/', 'https://invextherapeutics.com/contact-us/', '#elementor-action%3Aaction%3Dpopup%3Aopen%26settings%3DeyJpZCI6IjQwIiwidG9nZ2xlIjpmYWxzZX0%3D', 'https://invextherapeutics.com/corporate-governance/', 'https://invextherapeutics.com/corporate-governance/', 'https://invextherapeutics.com/asx-announcements/', 'https://invextherapeutics.com/asx-announcements/', 'https://invextherapeutics.com/presentations/', 'https://invextherapeutics.com/presentations/', 'https://invextherapeutics.com/articles/', 'https://invextherapeutics.com/articles/', 'https://invextherapeutics.com/contacts/', 'https://invextherapeutics.com/contacts/', 'https://twitter.com/invexthera_asx', 'https://www.youtube.com/channel/UC3c5xQ9XxcwHLHTUXMCXs6g', 'https://www.linkedin.com/company/invextherapeutics/', '/disclaimer', 'http://anomaly.com.au/', 'https://invextherapeutics.com/', '#', 'https://invextherapeutics.com/company-overview/', 'https://invextherapeutics.com/directors-management/', 'https://invextherapeutics.com/corporate-governance/', 'https://invextherapeutics.com/development-strategy/', '#', '#', 'https://invextherapeutics.com/asx-announcements/', 'https://invextherapeutics.com/company-reports/', 'https://invextherapeutics.com/presentations/', 'https://invextherapeutics.com/analyst-reports/', 'https://invextherapeutics.com/share-registry/', 'https://invextherapeutics.com/contacts/', 'https://invextherapeutics.com/publications/', 'https://invextherapeutics.com/fact-sheets/', '#', 'https://invextherapeutics.com/articles/', 'https://invextherapeutics.com/careers/', 'https://invextherapeutics.com/careers/current-openings/', 'https://invextherapeutics.com/contact-us/']",
    "images": "https://invextherapeutics.com/wp-content/uploads/2022/04/invex-therapeutics-logo.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/corporate-governace-icon.svg, http://invextherapeutics.com/wp-content/uploads/2022/04/asx-announcements-icon.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/annual-reports-icon.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/presentations-icon.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/media-icon.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/investor-information-icon.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/partner-preview.png, https://invextherapeutics.com/wp-content/uploads/2022/04/partner-preview-2.png, https://invextherapeutics.com/wp-content/uploads/2022/04/Premier_Research_Logo.jpg, https://invextherapeutics.com/wp-content/uploads/2022/04/University_Hospitals_Birmingham_NHS_Foundation_Trust_logo.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/MDT_logo.png, https://invextherapeutics.com/wp-content/uploads/2022/04/Iowa.png, https://invextherapeutics.com/wp-content/uploads/2022/04/university-of-birmingham-1024x242.png, https://invextherapeutics.com/wp-content/uploads/2022/04/partner-preview-2.png, https://invextherapeutics.com/wp-content/uploads/2022/04/Premier_Research_Logo.jpg, https://invextherapeutics.com/wp-content/uploads/2022/04/University_Hospitals_Birmingham_NHS_Foundation_Trust_logo.svg, https://invextherapeutics.com/wp-content/uploads/2022/04/MDT_logo.png, https://invextherapeutics.com/wp-content/uploads/2022/04/Iowa.png",
    "company_logo_link": "https://invextherapeutics.com/wp-content/uploads/2022/04/invex-therapeutics-logo.svg"
}